Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
143,892,500
-
Total 13F shares
-
129,359,736
-
Share change
-
+1,191,461
-
Total reported value
-
$420,530,224
-
Put/Call ratio
-
3.4%
-
Price per share
-
$3.25
-
Number of holders
-
159
-
Value change
-
+$4,827,354
-
Number of buys
-
70
-
Number of sells
-
78
Institutional Holders of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI) as of Q4 2025
As of 31 Dec 2025,
MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI) was held by
159 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
129,359,736 shares.
The largest 10 holders included
GTCR LLC, BlackRock, Inc., 12 West Capital Management LP, BRAIDWELL LP, VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., MACKENZIE FINANCIAL CORP, RENAISSANCE TECHNOLOGIES LLC, Monaco Asset Management SAM, and MORGAN STANLEY.
This page lists
159
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.